文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症心脑血管急症

神经重症监护病房中的急性肾损伤

Acute Kidney Injury at the Neurocritical Care Unit.
PubMed 文献 · Neurocrit Care · 2021-09-13
一句话结论神经重症患者AKI发生率为11.6%,需透析的3期AKI为3%~12%,是预后不良的独立预测因素。

本文是一篇关于神经重症患者急性肾损伤(AKI)的综述,聚焦其流行病学、病因、机制及脑-肾轴关系。文中报告神经重症患者AKI发生率为11.6%,按KDIGO分期需透析的3期AKI发生率为3%~12%。此类患者较年轻、合并症少但风险谱不同,病因为创伤性AKI、脓毒症、交感神经过度兴奋、肾小管上皮病变、高氯血症、肾毒性药物及肾灌注不足等。AKI是多种事件叠加的结果,涉及脑-肾生理连接直接改变及神经重症特有治疗相关损伤,综述还讨论了体外治疗的使用与风险。

要点

  • 神经重症患者AKI发生率为11.6%,按KDIGO分期需透析的3期AKI发生率为3%~12%。
  • 神经重症患者较年轻、合并症少,但风险谱不同,与其接受的诊断和治疗操作相关。
  • AKI是神经重症患者临床结局更差的独立预测因素。
  • 病因包括创伤性AKI、脓毒症、交感神经过度兴奋、肾小管上皮病变、高氯血症、肾毒性药物及肾灌注不足。
  • 脑-肾轴生理连接的直接改变及神经重症特有治疗相关损伤是两类重要机制。

适用人群与场景

  • 神经重症监护病房收治的神经重症患者;原文未提及具体纳入/排除标准。

诊断标准与关键阈值

  • 采用KDIGO(Kidney Disease: Improving Global Outcomes)分期,3期AKI为需透析者,原文报告其发生率为3%~12%。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 综述汇总:神经重症患者AKI发生率为11.6%,KDIGO 3期(需透析)AKI发生率为3%~12%。
  • 神经重症患者较年轻、合并症较少,但因诊断和治疗操作而具有不同风险谱。
  • AKI病因为创伤性AKI、脓毒症、交感神经过度兴奋、肾小管上皮病变、高氯血症、肾毒性药物及肾灌注不足等。
  • 机制涉及脑-肾生理连接直接改变及神经重症特有治疗相关损伤,部分机制尚不明确。
  • 综述还讨论了体外治疗在该人群中的使用与风险。

证据类型、等级与局限

  • 综述(review);原文未提及证据等级或推荐强度;局限性:非系统评价,未提供原始研究设计细节。

对床旁实践的改变

  • 神经重症患者应关注AKI风险,因其为预后不良的独立预测因素,需监测肾功能。
  • 注意规避或监测原文列出的可干预因素:高氯血症、肾毒性药物、肾灌注不足。
  • 使用体外治疗时需权衡原文所述的风险。

指南或共识出处

  • 原文未提及具体指南或共识名称,仅引用KDIGO分期标准。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

Neurocritical care has advanced substantially in recent decades, allowing doctors to treat patients with more complicated conditions who require a multidisciplinary approach to achieve better clinical outcomes. In neurocritical patients, nonneurological complications such as acute kidney injury (AKI) are independent predictors of worse clinical outcomes. Different research groups have reported an AKI incidence of 11.6% and an incidence of stage 3 AKI, according to the Kidney Disease: Improving Global Outcomes, that requires dialysis of 3% to 12% in neurocritical patients. These patients tend to be younger, have less comorbidity, and have a different risk profile, given the diagnostic and therapeutic procedures they undergo. Trauma-induced AKI, sepsis, sympathetic overstimulation, tubular epitheliopathy, hyperchloremia, use of nephrotoxic drugs, and renal hypoperfusion are some of the causes of AKI in neurocritical patients. AKI is the result of a sum of events, although the mechanisms underlying many of them remain uncertain; however, two important causes that merit mention are direct alteration of the physiological brain-kidney connection and exposure to injury as a result of the specific medical management and well-established therapies that neurocritical patients are subjected to. This review will focus on AKI in neurocritical care patients. Specifically, it will discuss its epidemiology, causes, associated mechanisms, and relationship to the brain-kidney axis. Additionally, the use and risks of extracorporeal therapies in this group of patients will be reviewed.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Ramírez-Guerrero G, Baghetti-Hernández R, Ronco C, et al. Acute Kidney Injury at the Neurocritical Care Unit. Neurocrit Care. 2021. PMID: 34518967. doi:10.1007/s12028-021-01345-7

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。